2021
DOI: 10.7759/cureus.13420
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 23 publications
1
10
0
Order By: Relevance
“…Similar to previous studies ( Chakinala et al, 2021 , Dalekos et al, 2021 , Emami et al, 2020 , Jordan et al, 2020 , Kyriazopoulou et al, 2021 , Li et al, 2021 , Rydyznski Moderbacher et al, 2020 ) , we demonstrated that older age and underlying comorbidities - including severe obesity, chronic heart and respiratory disease and additional chronic disorders - significantly affected the phenotype of SARS-CoV-2 infection. Furthermore, we observed that patients carrying the B allele (rs1800450) of the MBL2 gene also displayed worsened clinical presentation, as these patients more frequently required hospitalization because of pneumonia necessitating supplemental oxygen administration.…”
Section: Discussionsupporting
confidence: 91%
“…Similar to previous studies ( Chakinala et al, 2021 , Dalekos et al, 2021 , Emami et al, 2020 , Jordan et al, 2020 , Kyriazopoulou et al, 2021 , Li et al, 2021 , Rydyznski Moderbacher et al, 2020 ) , we demonstrated that older age and underlying comorbidities - including severe obesity, chronic heart and respiratory disease and additional chronic disorders - significantly affected the phenotype of SARS-CoV-2 infection. Furthermore, we observed that patients carrying the B allele (rs1800450) of the MBL2 gene also displayed worsened clinical presentation, as these patients more frequently required hospitalization because of pneumonia necessitating supplemental oxygen administration.…”
Section: Discussionsupporting
confidence: 91%
“…A recent meta-analysis of 29,750 patients identified that the prevalence of HTN and cardiovascular disease (CVD) in SARS-CoV-2 patients was 32.7% and 18.2%, respectively. Although this study reported that neither pre-existing HTN nor CVD was associated with greater mortality, they did report that CVD was associated with greater levels of invasive mechanical ventilation [58]. In contrast, earlier studies have reported that poor outcomes are significantly greater for HTN and CVD patients suffering from SARS-CoV-2 [59], with one suggesting the case-fatality rate to be double for HTN and over triple for CVD [60].…”
Section: Hypertension and Cardiovascular Morbiditymentioning
confidence: 61%
“…The mechanisms underlying disease severity in cases with HTN and CVD are not entirely clear. It is suggested that underlying CVD can be exacerbated by myocyte damage caused by hypoxia, in addition to the cytokine storm discussed above [58]. Further to this, people with HTN are often on anti-hypertensive medication such as ACE inhibitors and angiotensin receptor blockers.…”
Section: Hypertension and Cardiovascular Morbiditymentioning
confidence: 99%
“…We noticed that Covid-19 infection was significantly associated with pre-existing HTN (p = 0.002). Pre-existing HTN was reported to present in up to is 32.7% amongst adult Covid-19 infected patients [27]. In children; a systemic review published by Rodriguez-Gonzalez and his colleagues revealed that; cardiovascular involvement seems to be a relevant factor of SARS-CoV-2 infection.…”
Section: Discussionmentioning
confidence: 99%